abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Cost of Revenue
$10.91M
TTM · Period ending: · USD
HQL Cost of Revenue
Latest reported$10.91Mperiod ending
Latest reported$10.91Mperiod ending
HQL Cost of Revenue ($1.60M → $10.91M)
Annual cost of revenue
High-resolution chart · PNG
HQL cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 4,970,690 | |
| 5,357,252 | |
| 5,244,047 | |
| 5,548,950 | |
| 6,076,036 | |
| 5,206,018 | |
| 0 | |
| 0 | |
| 4,609,340 | |
| 4,948,699 | |
| 5,647,790 | |
| 4,140,000 | |
| 3,100,000 | |
| 2,480,000 | |
| 3,020,000 | |
| 2,990,000 | |
| 2,850,000 | |
| 3,760,000 | |
| 3,620,000 | |
| 2,930,000 | |
| 2,810,000 | |
| 2,780,000 | |
| 2,440,000 | |
| 2,860,000 | |
| 3,260,000 | |
| 1,640,000 | |
| 1,630,000 | |
| 1,600,000 |